-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Insulet, Lowers Price Target to $219

Benzinga·06/12/2026 14:17:29
Listen to the news
Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $250 to $219.